Primary Health Properties, the UK's leading investor in modern primary healthcare facilities, will announce its preliminary results for the year ended 31 December 2016 on Thursday 16 February 2017.
A presentation for analysts will be held on the day at 9.30am at the offices of Bell Pottinger, 6th floor, Holborn Gate, 330 High Holborn, London WC1V 7QD. There will also be a conference call facility.
-ends-
For further information, please contact:
Bell Pottinger Tel: 0203 772 2582
David Rydell / Elizabeth Snow / Eve Kirmatzis
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.